DNA double-stranded breaks (DSBs) elicit a checkpoint response that causes a delay in cell cycle progression. Early in the checkpoint response, histone H2AX is phosphorylated in the chromatin region flanking the DSB by ATM/ATR and DNA-PK kinases. The resulting foci of phosphorylated H2AX (c-H2AX) serve as a platform for recruitment and retention of additional components of the checkpoint-signaling cascade that enhance checkpoint signaling and DSB repair. Upon repair, both the assembled protein complexes and the chromatin modifications are removed to quench the checkpoint signal. In this study, we show that the DNA damage-responsive Wip1 phosphatase is bound to chromatin. Moreover, Wip1 directly dephosphorylates c-H2AX and cells depleted of Wip1 fail to dephosphorylate c-H2AX during checkpoint recovery. Conversely, premature activation of Wip1 leads to displacement of MDC1 from damage foci and prevents activation of the checkpoint. Taken together, our data show that Wip1 has an essential role in dephosphorylation of c-H2AX to silence the checkpoint and restore chromatin structure once DNA damage is repaired.
Introduction
The DNA damage checkpoint is activated in response to genotoxic stress to inhibit further cell cycle progression and promote repair of the damaged DNA . One of the earliest events that occurs at chromatin surrounding a DNA double-strand break is phosphorylation of the histone H2A variant H2AX at Ser-139 (g-H2AX) (Rogakou et al., 1998; Downs et al., 2000) . Exposure of cells to ionizing radiation, radiomimetic drugs or to replicative stress leads to H2AX phosphorylation by ataxia teleangiectasia mutated (ATM), DNA-PK (DNA-dependent protein kinase) and ATR (ATM-and Rad3-related) kinases, respectively (Shiloh, 2003) . Interestingly, g-H2AX is not present only at the double-strand break but instead stretches out over large regions of the flanking chromatin (Rogakou et al., 1998; Shroff et al., 2004) . Through phosphorylationdependent protein-protein interactions, gH2AX recruits multiple DNA damage response proteins to regions of damaged chromatin (Foster and Downs, 2005) . Mediator of DNA damage checkpoint 1 (MDC1) is an adaptor protein that directly binds to g-H2AX and has an essential role in the amplification of the DNA damage signal by promoting recruitment of the MRN complex (Mre11-Rad50-NBS1), ATM, breast cancer type 1 susceptibility protein, p53-binding protein 1 and the ubiquitin ligases RNF8 and RNF168 (ring-finger proteins 8 and 168) (Stucki et al., 2005; Mailand et al., 2007; Doil et al., 2009; Stewart et al., 2009) . Together DNA damage response proteins accumulating at sites of damaged chromatin activate checkpoint kinases Chk1 and Chk2, which modify multiple substrates and propagate the checkpoint signal . Separately from its function in checkpoint activation, gH2AX may also directly participate in the repair of damaged DNA by stabilization of the broken ends and by recruiting repair factors (Celeste et al., 2003b) . Importantly, H2AX haploinsufficiency causes genomic instability and in the absence of p53 enhances the susceptibility to cancer (Bassing et al., 2003; Celeste et al., 2003a) .
After repairing the damaged DNA, gH2AX foci disappear and the checkpoint is switched off to allow re-entry into the cell cycle (checkpoint recovery). In principle, g-H2AX may be dephosphorylated, or can be removed from chromatin through histone exchange (Berkovich et al., 2007; Svetlova et al., 2007; Heo et al., 2008) . In yeast, gH2A is first released from chromatin and subsequently dephosphorylated by HTP-C (histone H2A phosphatase complex) containing the Pph3 phosphatase (Keogh et al., 2006) . The closest mammalian Pph3 homologue, protein phosphatase PP4 has recently been reported to counteract ATR-dependent phosphorylation of H2AX specifically during S phase (Chowdhury et al., 2008) . Depletion of PP4 by RNAi was shown to impede the repair of DNA damage that occurs naturally during replication (Chowdhury et al., 2008; Nakada et al., 2008) . In addition, the protein phosphatase PP2A has been shown to remove g-H2AX in mammalian cells during the repair of exogenously induced DNA damage (Chowdhury et al., 2005) . However, the yeast PP2A homologue does not appear to be involved in DNA damage response (Keogh et al., 2006) suggesting that the phosphatases responsible for gH2AX removal may not be evolutionarily conserved.
The wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) is a monomeric serine/threonine phosphatase that is induced in response to DNA damage in a p53-dependent manner (Fiscella et al., 1997) . Importantly, Wip1 has strong oncogenic potential and Wip1 is amplified or overexpressed in multiple human cancer types, predominantly those that still retain functional p53 (Li et al., 2002; Saito-Ohara et al., 2003; Bulavin et al., 2004; Castellino et al., 2008) . Conversely, Wip1 knockout mice are partially resistant to oncogeneinduced cancer development, indicating that inhibition of Wip1 activity may potentially be beneficial for cancer therapy (Bulavin et al., 2004; Harrison et al., 2004; Belova et al., 2005; Shreeram et al., 2006b) . Wip1 dephosphorylates multiple DNA damage response proteins including Chk1, Chk2, p53, ATM, Mdm2 and p38 (Takekawa et al., 2000; Lu et al., 2005 Lu et al., , 2007 Fujimoto et al., 2006; Shreeram et al., 2006a) , and is considered as a major homeostatic regulator of the DNA damage response. Here, we identify Wip1 as the chromatin-bound phosphatase responsible for the removal of gH2AX from DNA damage foci.
Results

Wip1 is tightly bound to chromatin
Wip1 consists of a conserved catalytic domain and a C-terminal domain containing two putative nuclear localization signals that target exogenously expressed Wip1 to the nucleus (Fiscella et al., 1997) . In addition, we also find that endogenous Wip1 is predominantly nuclear (Figure 1a) . To analyze the dynamics of Wip1 localization, we constructed an EGFP-tagged Wip1 and used time-lapse microscopy to track its localization throughout the cell cycle. During interphase, EGFPWip1 was present in the nucleus, and in mitosis it followed chromosomes to the metaphase plate and subsequently in the two daughter cells in telophase, suggesting that Wip1 can associate with chromatin ( Figure 1b) . The same result was obtained with the Wip1 C-terminally tagged with mCherry, indicating that the chromatin localization is because of specific targeting of Wip1 (data not shown). Fluorescence recovery after photobleaching analysis revealed a slow turnover of the EGFP-Wip1 with a recovery half-time t 1/2 E1 min, significantly longer than the half-time for EGFP-TPX2 (t 1/2 E7 s), a nuclear protein of comparable size (Figure 1c) . Although EGFP-Wip1 is not completely immobile as EGFP-Histone H2B, this strongly indicates that EGFP-Wip1 is not freely diffusing within the nucleus. Furthermore, Wip1 co-distributed in the insoluble nuclear fraction together with histones, whereas soluble proteins, such as tubulin or 14-3-3s, remained in the cytosolic fraction, again indicating that Wip1 associates with chromatin ( Figure 1d , Supplementary Figure 1 ). Besides, after DNA damage, Wip1 codistributed with ATM and its substrate pS15-p53 in the chromatin fraction (Figure 1d ). Interestingly, we found that H2AX is present in Wip1 protein complexes obtained by immuno-precipitation (Figure 1e , Supplementary Figure 1 ). On the contrary, CENP-A, another histone variant, was not present in Wip1 immunocomplexes, suggesting that in cells Wip1 specifically interacts with H2AX and not with centromeric chromatin. Taken together, our data indicate that Wip1 is tightly bound to chromatin throughout the cell cycle and interacts with H2AX.
Wip1 dephosphorylates pSer139 of H2AX in vitro and in vivo Wip1 is known to recognize and dephosphorylate pSQ/ TQ motifs on substrates of ATM/ATR kinases activated during the DNA damage response (Yamaguchi et al., 2007) and thus we wondered whether Wip1 might also dephosphorylate pSer-139 of Histone H2AX. To test this we established an in vitro phosphatase assay in which we incubated immunopurified Wip1 with histones isolated from cells exposed to DNA damage. Interestingly, wild-type Wip1 but not phosphatase-deficient Wip1-D314A was able to fully dephosphorylate gH2AX (Figure 2a ). To test if the observed activity of Wip1 was specific for gH2AX, we performed the phosphatase assay using histones purified from mitotic cells. Importantly, Wip1 was unable to dephosphorylate pSer-10 of Histone H3, showing that Wip1 does not generally dephosphorylate histones ( Figure 2a ). As gH2AX can be dephosphorylated by PP2A and PP4 phosphatases in vitro (Chowdhury et al., 2005 (Chowdhury et al., , 2008 , we wished to exclude the possibility that the phosphatase activity observed in Wip1 immunoprecipitates may be in fact caused by the presence of co-immunoprecipitated PP2A or PP4. Importantly, purified Wip1 efficiently dephosphorylated gH2AX even in the presence of 0.5 mM okadaic acid (50 Â IC 50 for PP1 and 5.10 3 Â IC 50 for PP2A) confirming that gH2AX is not dephosphorylated by an okadaic acid-sensitive phosphatase (Figure 2b) . Moreover, recombinant His-Wip1 was able to dephosphorylate a synthetic phosphopeptide corresponding to the pSer139-H2AX albeit somewhat less efficiently than a peptide corresponding to pSer15-p53 (Supplementary Figure 2A) , which is in agreement with previous reports (Shreeram et al., 2006a; Yamaguchi et al., 2007) .
Subsequently, we tested whether Wip1 could dephosphorylate gH2AX in intact cells. To this end, we exposed cells to 0.5 mM doxorubicin and then microinjected Wip1-FLAG expression plasmid. Microinjection of Wip1 completely removed gH2AX foci, whereas neighboring non-injected cells or control-injected cells Figure 2B ). Taken together, these data show that Wip1 can promote gH2AX dephosphorylation, both in vitro and in vivo.
Wip1 localizes to DNA damage foci In response to DNA damage, H2AX becomes phosphorylated at sites of damaged chromatin. Therefore, we asked whether Wip1 redistributes to DNA damage foci within the nucleus following DNA damage. We induced DNA damage by microirradiation in cells doubly transfected with mCherry-Wip1 and EGFP-MDC1 as a marker of DNA damage foci. In agreement with published data EGFP-MDC1 rapidly redistributed to irradiation-induced foci (Xu and Stern, 2003) . Importantly mCherry-Wip1 co-localized with MDC1 in irradiation-induced foci (Figure 3a ), although the dynamics of its redistribution to these foci was somewhat slower compared with MDC1. To test whether endogenous Wip1 is also recruited to DNA damage foci, we microirradiated cells and stained them for Wip1 and gH2AX. Following DNA damage, Wip1 and gH2AX colocalized in many irradiation-induced foci, indicating that endogenous Wip1 can be recruited to DNA damage foci ( Figure 3b ). The fact that Wip1 is present in some, but not all, gH2AX foci, suggests that localization of Wip1 is tightly regulated during the DNA damage response. In fact, both checkpoint activity and Wip1 levels have recently been shown to oscillate during the checkpoint response following DNA damage (Batchelor et al., 2008) , and therefore its recruitment to damage foci in a subset of cells might reflect this oscillatory behavior.
Dephosphorylation of gH2AX by Wip1 does not depend on inhibition of ATM Although our data indicate that Wip1 can dephosphorylate gH2AX directly, it is also possible that the effect of Wip1 on gH2AX in vivo is mediated via inactivation of kinases responsible for gH2AX phosphorylation. Indeed, Wip1 has been shown to dephosphorylate ATM at pSer-1981 (Shreeram et al., 2006a) , and while phosphorylation of this site is not required for activation of ATM, it correlates with ATM kinase activity (Lee and Paull, 2005; Pellegrini et al., 2006; Daniel et al., 2008; Reinhardt and Yaffe, 2009 ). In addition, accumulation of the MRN complex at doublestranded breaks is required for activation of ATM (Berkovich et al., 2007; Lee and Paull, 2007) and thus defects in gH2AX formation caused by Wip1 may affect the activation of ATM at sites of DNA damage. To test whether the observed dephosphorylation of gH2AX in vivo depends on the loss of the ATM activity we first Wip1 dephosphorylates cH2AX L Macůrek et al compared the effect of inducible Wip1 expression with the inhibition of ATM kinase induced by treatment with caffeine, a general PI-3 kinase family inhibitor that efficiently blocks ATM, ATR and DNA-PK (Sarkaria et al., 1999; Block et al., 2004) . Importantly, brief induction of Wip1 expression (but not the phosphatase dead Wip1) was sufficient to strongly reduce gH2AX levels, whereas caffeine-induced inhibition of ATM, ATR and DNA-PK did not result in a significant reduction of gH2AX levels during this time period (Supplementary Figure 3A) . Nonetheless, caffeine treatment efficiently reduced pS15-p53 phosphorylation (a direct substrate of ATM (Canman et al., 1998) ), and the expression levels of the p53 target gene p21 Figure 3A) . Besides, cells treated with caffeine recovered from the DNA damage-induced arrest and entered mitosis within 8 h, indicating that the checkpoint was successfully silenced (data not shown). Next, we investigated the effect of Wip1 expression on gH2AX foci formation in an ATM-deficient cell line. In agreement with published data, gH2AX foci are formed upon DNA damage also in the absence of ATM (Supplementary Figure 3B and (Goodarzi et al., 2008) ). Interestingly, expression of EGFP-Wip1 but not EGFP-TPX2 interfered with the formation of gH2AX foci in ATM deficient cells (Supplementary Figures 3B and C) . Collectively, these data indicate that mere inhibition of ATM activity is insufficient to reduce gH2AX levels and show that the effect of Wip1 on gH2AX levels occurs independently of ATM inactivation.
Wip1 controls dephosphorylation of gH2AX during recovery If Wip1 is an important phosphatase for gH2AX, depletion of Wip1 should interfere with the removal of gH2AX. Therefore, we depleted Wip1 by RNAi, challenged cells with etoposide and probed for gH2AX levels. Indeed, U2OS cells depleted of Wip1 showed sustained high levels of gH2AX after DNA damage, indicating that Wip1 activity is required for the efficient removal of gH2AX (Figures 4a and b) . Similar results were observed when DNA damage was induced by doxorubicine (Supplementary Figure 4) . Similarly, HCT116 cells depleted of Wip1 showed impaired removal of gH2AX 12 h after treatment with etoposide, indicating that the observed phenotype is not restricted to U2OS cells (Figure 4c ). Essentially, treatment of both cell types with a selective ATM inhibitor efficiently reduced ATM autophosphorylation at pSer-1981, but was not sufficient to abolish the elevated gH2AX levels present in Wip1-depleted cells (Figures 4a and c and data not shown). The close correlation between Wip1 depletion and high levels of gH2AX was also observed in ATM-deficient cells, although the reduction of gH2AX levels in the control-depleted cells was less pronounced compared with U2OS cells (Figure 4d ).
Microscopic analysis of individual cells revealed a relatively low basal level of Wip1 expression in AT cells (Supplementary Figure 5) . In fact, only a fraction (B47%, n ¼ 171) of control-depleted cells expressed detectable levels of Wip1 10 h after removal of etoposide (Supplementary Figure 5) . Importantly, Wip1 positive cells always showed strongly reduced gH2AX staining (82/82), whereas the majority of cells with undetectable Wip1 retained high gH2AX levels (69/89). In contrast, all Wip1-depleted cells remained highly positive for gH2AX 10 h after release from etoposide (Supplementary Figure 5 ). Collectively these data indicate that the elevated gH2AX levels after Wip1 RNAi are not because of Wip1 counteracting ATM. Moreover, regulation of Wip1 expression levels emerges as an important factor for the ability to dephosphorylate gH2AX. Taken together, our data suggest that Wip1 is a direct phosphatase of gH2AX and that the presence of Wip1 is required for efficient dephosphorylation of gH2AX in vivo.
We and others have observed that depletion of Wip1 prevents recovery from intra-S and G2 checkpoints induced by various DNA damaging agents (Lu et al., 2005; Lindqvist et al., 2009) . In contrast, overexpression of Wip1 before DNA damage prevents checkpoint activation and leads to checkpoint override. Indeed, cells expressing Wip1 before exposure to a mild DNA damage fail to activate the checkpoint and progress to mitosis (Figure 4e ) (Shreeram et al., 2006a) . However, this phenotype probably represents a cumulative effect of Wip1 phosphatase activity on multiple proteins involved in the DNA damage pathway. To address whether direct regulation of gH2AX levels might also be involved in this process, we assayed the formation of DNA damage-induced MDC1-EGFP foci in cells that inducibly express Wip1. MDC1 binds directly to gH2AX via its BRCT domain and this interaction is independent of the downstream activation of DNA damage response pathway (Stucki et al., 2005) . Whereas the control cells formed MDC1-GFP foci after exposure to 0.2 mM doxorubicin, cells induced to express Wip1 failed to form discrete MDC1-GFP foci and showed only diffuse nuclear staining (Figure 4f and Supplemen- 
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L Macůrek et al tary Figure 6 ). Similarly, cells induced to express Wip1 did not form gH2AX foci, whereas cells without induction of Wip1 expression were strongly positive for gH2AX (Supplementary Figure 6) . Taken together, expression of gH2AX and formation of MDC1 foci, both necessary for the checkpoint activation, is severely affected in cells expressing ectopic Wip1. Thus, expression of Wip1 before DNA damage prevents activation of the checkpoint and allows cells to progress to mitosis without repairing damaged DNA.
Discussion
Activation of checkpoint mechanisms following the exposure to DNA damage is essential to maintain genomic integrity and to prevent potential cancer development . Phosphorylation of H2AX by ATM/ATR kinases occurs rapidly after appearance of double-stranded breaks and is necessary for the formation of DNA damage foci at the surrounding chromatin. Subsequently, many other
Wip1 dephosphorylates cH2AX L Macůrek et al substrates are modified by activated ATM/ATR and Chk1/Chk2 kinases resulting in the activation of checkpoint, DNA repair and/or apoptosis. Conversely, these pathways need to be switched off to allow re-entry into the cell cycle once DNA has been repaired. In mammalian cells, the phosphatase Wip1 has been shown to act on multiple substrates phosphorylated after DNA damage including p53, Chk2, Chk1, p38 and ATM and may thus act as a major homeostatic factor inactivating the checkpoint signaling . Here, we show that Wip1 is a chromatin-associated phosphatase, that binds to H2AX and can directly dephosphorylate gH2AX (Figures 1 and 2) . Under normal conditions, Wip1 levels are relatively low and its expression increases after damage (Fiscella et al., 1997) . The low initial level of Wip1 enables cells to fully activate the checkpoint and allows the time required for DNA repair. Stabilization of p53 mediated by its phosphorylation by ATM and Chk1/2 kinases increases the transcription of the Wip1 gene. The induction of Wip1 activity creates a feedback loop that leads to inactivation of p53 and other checkpoint components . The organization of p53, Wip1 and other checkpoint components in such a feedback loop results in oscillations in the activity of the checkpoint signaling (Batchelor et al., 2008) . At present, it is unclear what the relative contribution is of single substrates of Wip1 in silencing the checkpoint. Arguably, inactivation of proteins standing high in the DNA damage signaling pathway would enable the most efficient silencing of the checkpoint. Thus, overexpression of Wip1 before damage prevents formation of MDC1 foci and disables activation of the checkpoint (Figure 4) . On the other hand, acting on multiple downstream effectors could provide a fine-tuning of the checkpoint response and have an essential role during the recovery phase when the checkpoint has to be completely silenced and the altered chromatin has to be repaired.
Wip1 is not conserved in lower organisms, indicating that Wip1 may have evolved together with p53 to counteract its activity in the checkpoint signaling. Thus, yeast rely on a single PP4 phosphatase homologue Pph3 to silence the checkpoint by removing gH2A (Keogh et al., 2006) . In addition, this function appears to be partially preserved in mammalian cells where PP4 contributes to the dephosphorylation of gH2AX that is naturally present at basal levels during replication (Chowdhury et al., 2008) . However, dealing with higher levels of DNA damage, caused either by oncogenic stress or by exogenous agents, may require additional phosphatase(s) to silence the checkpoint (Chowdhury et al., 2008) . PP2A has been shown to inactivate ATM and gH2AX, however, the mechanisms regulating the timing of PP2A activation in DNA damage are still unclear (Goodarzi et al., 2004; Chowdhury et al., 2005; Petersen et al., 2006) . Our data indicate that Wip1 has an important role in the removal of gH2AX from chromatin. Importantly, expression of Wip1 is tightly coupled to DNA damage to prevent premature checkpoint silencing. We found that Wip1 was recruited to the damage foci several minutes after the recruitment of MDC1. Importantly, this was done in cells constitutively expressing Wip1. Therefore, recruitment of endogenous Wip1 is likely to occur even later, as its expression first needs to be induced by p53. Interestingly, endogenous Wip1 was seen in foci in a subset of cells, indicating that besides the delay in Wip1 expression, recruitment might also be regulated by posttranslational modifications to prevent inappropriate dephosphorylation of gH2AX. Thus, the activity of Wip1 toward gH2AX during the DNA damage response appears to be restrained by the delayed induction of Wip1 as well as through controlled recruitment of Wip1 to the modified chromatin. Apparently, it will be interesting to resolve if additional levels of regulation, such as control of Wip1 activity, also has a role in the timing of gH2AX dephosphorylation.
Wip1 has emerged as a global checkpoint regulator that targets multiple DNA damage checkpoint proteins. This makes Wip1 an attractive candidate to help premature tumor cells overcome a DDR-dependent barrier against tumor progression (Halazonetis et al., 2008) . Here, we show that Wip1 dephosphorylates gH2AX, a central regulator of the checkpoint response. As gH2AX is responsible for recruitment of multiple checkpoint proteins to DNA damage foci, this offers a mechanistic insight as to how Wip1 can function as a homeostatic checkpoint regulator.
Materials and methods
Plasmids
Wip1-FLAG and MDC-EGFP plasmids were generous gifts from Dr Donehower and Dr Lukas, respectively. The coding sequence for full-length human Wip1 was subcloned in frame in pEGFP-C3, pmCherry-N1 (Clontech, Mountain View, CA, USA), pcdna4/TO (Invitrogen, Carlsbad, CA, USA) and pQE81L (Qiagen, Valencia, CA, USA) plasmids. To generate the phosphatase dead Wip1-D314A, a point-mutation was introduced by QuickChange Mutagenesis kit (Stratagene, La Jolla, CA, USA). The pRS-Wip1 shRNA construct targeting human Wip1 (GGATGACTTTGTCAGAGCT) was generated by ligating the targeting sequence into pRetroSuper vector (Brummelkamp et al., 2002) and was described elsewhere (Lindqvist et al., 2009) . pLKO.1-based lentiviral vectors targeting luciferase or Wip1 (CGAGAGAATGTCCAAGGTGTA for pLKO-H6, and GTGGACAATCAGGGAAACTTT for pLKO-H4) were from Sigma (St Louis, MO, USA).
Cell lines
Human osteosarcoma U2OS, colorectal carcinoma HCT116 p53 þ / þ , HCT116 p53À/À and ataxia teleangiectasia fibroblasts GM05849 (Coriell Institute, Camden, NJ, USA) cells were grown at 37 1C and 5% CO 2 in DMEM (Invitrogen) supplemented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. The U2TR cell line was constructed by stable transfection of U2OS cells with a plasmid expressing the tetracycline repressor and routinely grown in Tet-approved FBS (Clontech) as described (Macurek et al., 2008) . U2TR-based cell lines inducibly expressing either wild type or phosphatase dead Wip1-FLAG were generated by transfection of pcdna4/TO-Wip1 and Wip-D314A plasmids, respectively, and subsequent selection with zeocine. To induce DNA damage in G2, cells were treated as described (Lindqvist et al., 2009) . In brief, cells were first synchronized Wip1 dephosphorylates cH2AX L Macůrek et al with thymidine (2.5 mM, 24 h), released into fresh media and 5 h post release incubated with doxorubicin (0.2-1 mM, 1 h) or etoposide (10 mM, 1-2 h). Alternatively, asynchronic cells were exposed to DNA damage. Where indicated, checkpoint recovery was induced by addition of caffeine for 8 h (2.5 mM) as described (Macurek et al., 2008) . U2OS cells were transfected using a standard calcium phosphate procedure. Where indicated, GFPspectrin was cotransfected with plasmid DNA (Kalejta et al., 1997) . Lentiviral transduction of HCT116 cells was performed as described (Lindqvist et al., 2009 ).
Antibodies and reagents
The following antibodies were used in this study: anti-histone H2AX (#07-627), anti-pSer10-histone H3 (#06-570), and antipSer139-H2AX (#05-636) (Upstate, Billerica, MA, USA); anti-pSer15p53 (#9286), anti-pSer1981-ATM (#4526) and polyclonal anti-pSer139-H2AX (#2577) (Cell Signaling Technology, Danvers, MA, USA); anti-a-tubulin (t5168) and anti-FLAG (f3165) (Sigma); anti-p53 clone DO1 (sc126), anti-14-3-3sigma (sc7683), anti-14-3-3g (sc731) and rabbit anti-Wip1 (sc20712) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-ATM (nb100-104) (Novus Biological, Littleton, CO, USA); anti-CENP-A (ab13939, Abcam, Cambridge, MA, USA) and secondary AlexaFluor-568 and AlexaFluor-488 antibodies (Invitrogen). Selective ATM inhibitor (2-Morpholin-4-yl-6-thianthren-1-yl-pyran-4-one, KU55933) was purchased from Calbiochem (Nottingham, UK) and was used at 10 mM (Hickson et al., 2004) . ON-TARGETplus SMARTpool siRNA targeting Wip1 (#J-004554), luciferase or GAPDH were from Dharmacon (Lafayette, CO, USA) and were transfected using HiPerFect transfection reagent according to the manufacturer's recommendations (Qiagen).
Chromatin fractionation
Chromatin fractionation was performed as described (Xu and Stern, 2003) . Soluble cytosolic proteins were extracted from U2OS cells by incubating cells in buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 0.1% Triton X-100 and protease inhibitor cocktail) at 4 1C for 10 min and spinning down at 1500 g for 2 min. Soluble nuclear fraction was obtained by extraction of pelleted nuclei with an equal amount of buffer B (10 mM HEPES, pH 7.9, 3 mM EDTA, 0.2 mM EGTA, 1 mM DTT) and spinning down at 2000 g for 2 min. Where indicated, buffer B was supplemented with 150-300mM NaCl. Insoluble chromatin was washed with buffer B and finally resuspended in SDS sample buffer.
Immunoprecipitation
Cells were extracted by mild sonication in ice-cold extraction buffer [PBS pH 7.4, 0.1% Triton X-100, 2 mM EDTA, 1 mM EGTA, 0.5 mM DTT, 1 mM NaF, 25 mM b-glycerophosphate, 1 mM Na3VO4, protease inhibitors]. After sonication, TX-100 was adjusted to 1% (v/v) and cell extracts were clarified by 10 min centrifugation 10 000 g at 4 1C. Before immunoprecipitation, extracts were precleared for 1 h by incubation at 4 1C with empty sepharose beads. Immunoprecipitation was performed using anti-FLAG M2 agarose (Sigma). Samples were extensively washed with extraction buffer supplemented with 300 mM NaCl and eluted in SDS sample buffer. Where indicated, increased concentration of NaCl was present throughout the incubation with the cell extract.
Phosphatase assay
Crude histones were isolated by acidic extraction from cells exposed to doxorubicin (1 mM, O/N) or cells synchronized in mitosis by nocodazole (O/N) using a Histone purification kit (Active Motif, Carlsbad, CA, USA). Wip1 immunoprecipitates were washed twice in the phosphatase buffer [40 mM HEPES pH 7.4, 100 mM NaCl, 50 mM KCl, 1 mM EGTA, 50 mM MgCl2] and mixed with 3 mg of histones in 30ml phosphatase buffer and incubated for 30 min at 30 1C. As a positive control 200U of lphosphatase (New England Biolabs, Ipswich, MA, USA) were used. Where indicated 0.5 mM okadiac acid (OA; Calbiochem) was added in the reaction. Alternatively, we used 20-100 ng of HisWip1 purified from bacterial lysates and performed in vitro phosphatase assay as described (Lu et al., 2004) . The GGKKATQApSQEY (H2AX-pS139) and VEPPLpSQETFS (p53-pS15) peptides were synthesized using fmoc-based solid-phase chemistry, purified by reversed-phase HPLC and verified by mass spectrometry. Free phosphate was detected by Biomol Green Reagent (Enzo Life Sciences International, Plymouth, PA, USA).
Immunofluorescence microscopy, micro-irradiation and fluorescence recovery after photobleaching Immunofluorescence was performed as described (Lindqvist et al., 2007) . Images were acquired on a Zeiss LSM510 META microscope (Carl Zeiss, Jena, Germany) or a Deltavision RT imaging system (Applied Precision, Issaquah, WA, USA) using NA 1.4 objectives. Colocalization was assayed on deconvolved images using Softworx Explorer software (Applied Precision) and the colocalization plug-in in ImageJ (NIH) (http://rsbweb.nih. gov/ij/plugins/colocalization-finder.html). For time-lapse microscopy, cells were grown in a permanently heated chamber in Leibovitz L15 media (Invitrogen) and imaged on a Zeiss Axiovert 200 M microscope equipped with a Â 40 NA 1.3 objective. Images were acquired at 5 min intervals using a CCD camera and GFP filter cube (Chroma Technology, Rockingham, VT, USA). Where indicated, cells were microinjected with 0.1 mg/ml expression plasmid together with pEGFP (ratio 10:1) using an Eppendorf Micromanipulator 5171 coupled to a Transjector 5246. DNA damage by microirradiation was performed in MDC-EGFP expressing cells as described (Dinant et al., 2007) . Briefly, cells were presensitized by Hoechst-33342 (0.5 mg/ml) treatment for 1 h and microirradiated in indicated regions with a 405 nm laser (100% power). Fluorescence recovery after photobleaching was performed by bleaching the indicated region in the nucleus of Wip1-EGFP expressing cells by 488 nm laser (100% power, 200 iterations) followed by imaging in 30 s intervals for Wip-GFP or 2 s intervals for TPX2-GFP. Recovery half-time was calculated as (I E ÀI 0 )/2, where I E is a maximal intensity achieved after fluorescence recovery and I 0 is the minimal intensity after photobleaching. An unbleached region of the same size was used as a control.
Automated image analysis
Cells were grown in 96-well plates (Viewplate-96, Perkin Elmer, Waltham, MA, USA) and transfected with 20 nM siRNA. DNA damage was induced 36 h post-transfection by incubation with 10 mM etoposide for 1 h. At indicated time intervals, cells were fixed with 4% formaldehyde and methanol and were stained with DAPI and gH2AX or Wip1 antibodies. Image acquisition was performed using a Cellomics ArrayScan VTI (Thermo Scientific, Waltham, MA, USA) using a 20 Â 0.40 NA objective. Image analysis was performed using Cellomics ArrayScan HCS Reader (Thermo Scienctific). Nuclei were identified based on DAPI staining before measurement of nuclear gH2AX and Wip1 staining. After background correction, either the nuclear fluorescence intensity (Compartmental Analysis Bioapplication) or the amount of separate foci (Spot Detector Bioapplication) was assessed. Image analysis was performed on at least 400 cells per condition.
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